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There is a strong genetic risk for late-onset Alzheimer’s disease (AD), but so far few gene variants have been identified that reliably
contribute to that risk. A newly confirmed genetic risk allele C of the clusterin (CLU) gene variant rs11136000 is carried by88% of
Caucasians. The C allele confers a 1.16 greater odds of developing late-onset AD than the T allele. AD patients have reductions in regional
white matter integrity. We evaluated whether the CLU risk variant was similarly associated with lower white matter integrity in healthy
young humans. Evidence of early brain differences would offer a target for intervention decades before symptom onset.We scanned 398
healthy young adults (mean age, 23.6 2.2 years) with diffusion tensor imaging, a variation of magnetic resonance imaging sensitive to
white matter integrity in the living brain. We assessed genetic associations using mixed-model regression at each point in the brain to
map theprofile of these associationswithwhitematter integrity. EachCallele copyof theCLU variantwas associatedwith lower fractional
anisotropy—a widely accepted measure of white matter integrity—inmultiple brain regions, including several known to degenerate in
AD. These regions included the spleniumof the corpus callosum, the fornix, cingulum, and superior and inferior longitudinal fasciculi in
both brain hemispheres. Young healthy carriers of theCLU gene risk variant showed a distinct profile of lowerwhitematter integrity that
may increase vulnerability to developing AD later in life.
Introduction
Two recent genome-wide association studies identified and rep-
licated an association between risk for Alzheimer’s disease (AD)
and carrying the C allele of the single nucleotide polymorphism
(SNP) rs11136000 in the clusterin (also known as apolipoprotein
J) gene (CLU-C) (Harold et al., 2009; Lambert et al., 2009).
CLU-C confers a 1.16 greater odds of developing late-onset AD
than the T allele (Bertram et al., 2007). Approximately 36% of
Caucasians carry two copies of the risk-conferring allele (Bertram
et al., 2007), making this gene of great interest for public health.
AD traditionally has been considered a disease marked by
neuronal cell loss and widespread gray matter atrophy, but de-
generation of myelin in white matter fiber pathways is increas-
ingly considered a key disease component (Braak and Braak,
1996; Hua et al., 2008; Bartzokis, 2009). To evaluate how CLU-C
affects fiber integrity, we scanned 398 healthy young adults
(mean age, 23.6 2.2 years)with diffusion tensor imaging (DTI).
DTI is a variant of standard brain magnetic resonance imaging
(MRI) that is sensitive to fiber integrity and white matter micro-
structure. The most widely accepted DTI measure, fractional an-
isotropy (FA), evaluates the extent to which water diffusion is
directionally constrained. Higher FA generally reflects preferen-
tial diffusion alongmore intact, heavilymyelinated axons.Demy-
elination, neurological disease symptoms, and slowed nerve
conduction have been associated with lower FA in white matter
(Nucifora et al., 2007), suggesting that it may reflect reduced
white matter integrity.
White matter pathways deteriorate in AD due to primary ef-
fects of impaired myelination and secondary effects of neuronal
loss (Brun and Englund, 1986). In several studies of AD andmild
cognitive impairment, cognitive impairment has been associated
with reduced FA in the corpus callosum, fornix, cingulum, supe-
rior longitudinal fasciculus (SLF), and inferior longitudinal fas-
ciculus (ILF) (Liu et al., 2009; Stricker et al., 2009). Additionally,
the apolipoprotein E allele 4 (APOE4)—a widely confirmed ge-
netic risk factor for late-onset AD—is associatedwith lower FA in
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the parahippocampal white matter, splenium, and fronto-
occipital fasciculus of healthy older subjects (Nierenberg et al.,
2005; Persson et al., 2006; Smith et al., 2010).
CLU is a plausible candidate for modulating white matter
integrity, as both CLU and APOE encode apolipoproteins impli-
cated in AD risk. Additionally, clusterin (the gene product) is
implicated in lipid transport andmembrane recycling (Dati et al.,
2007), and in remyelination of nerve fibers in rats (Dati et al.,
2007). We hypothesized that young CLU-C carriers would show
reduced white matter integrity, quantifiable as lower FA in brain
regions implicated in AD. Such differences could help to explain
why the gene is associated with heightened risk for AD.
It is vital to discover how AD risk variants impact the living
brain to better understand disease development and to design
interventions for those at risk. Targeting subpopulations most
likely to show decline also boosts power for prevention and treat-
ment trials (Kohannim et al., 2010).
Materials andMethods
Subjects and genotype information. DTI scans and genotypes were ob-
tained for 468 right-handed Caucasians recruited as part of a project
examining brain structure and white matter integrity in healthy, young
adult Australian twins. We excluded 70 subjects for the following rea-
sons: 8were ancestry outliers; 58were technically inadequate scans; 3 had
ventricle size inconsistent with good health in a young person; and 1
lacked a genotype at rs11136000. Of the remaining 398 subjects (mean
age, 23.6  2.2 years; age range, 20–29 years), 92 were monozygotic
(MZ) twins, 147 were dizygotic (DZ) twins or triplets, 41 were singleton
siblings, and 118 were unrelated individuals. Genomic DNA samples
were analyzed on the Human610-Quad BeadChip (Illumina) according
to the manufacturer’s protocols (Infinium HD Assay; Super Protocol
Guide, revision A, May 2008). The CLU rs11136000 polymorphism was
T/T in 68 subjects (17.1%), C/T in 220 subjects (55.3%), and C/C in 110
subjects (27.6%). The frequency for the minor (T) allele (MAF) in unre-
lated subjects in our sample was 0.40, similar to previous reports in
healthy populations of European origin (Harold et al., 2009; Lambert et
al., 2009). The genotype distribution in our sample followed Hardy–
Weinberg equilibrium using a standard threshold of p 0.001 ( 2(1)
4.70, p 0.030). When we calculated the evidence for Hardy–Weinberg
equilibrium, the expected proportions of C/C and T/T genotypes com-
pared with observed values differed by small numbers that can be attrib-
uted to the effects of random sampling. These differences are unlikely to
indicate any ascertainment bias as these subjects were selected only be-
cause they are twins or singleton siblings of twins. They were originally
recruited for a melanoma study, and the cohort is composed of young
adults, meaning that there would not be any disease-related attrition that
could adversely impact the allele frequencies for an AD risk allele. We
therefore have no good reason to believe that those in the study have a
level of AD risk that is different from that of the general Australian
population from which our sample was drawn.
Verbal, performance, and full-scale intelligence quotient (IQ) stan-
dardized scores were derived from subtest scores of the Multidimen-
sional Aptitude Battery (MAB) (Jackson, 1984), which were available for
all but 20 subjects. TheMAB is similar to theWechsler Adult Intelligence
Scale (Wechsler, 1981) as it is composed of tests of verbal and perfor-
mance intelligence. Verbal IQ subtests included assessments of informa-
tion, arithmetic, and vocabulary. Performance IQ subtests included
spatial and object assembly. All subjects providedwritten, informed con-
sent. The study conformed to theNational Statement onEthical Conduct
in Human Research (2007) issued by the National Health and Medical
Research Council of Australia and was approved by the Queensland In-
stitute of Medical Research Human Research Ethics Committee.
Image acquisition.T1-weighted images of the brain were acquired with
an inversion recovery rapid gradient echo sequence on a 4 Tesla MRI
scanner (Medspec, Bruker) [acquisition parameters: inversion time, 700
ms; repetition time (TR), 1500 ms; echo time (TE), 3.35 ms; flip angle
8°; slice thickness  0.9 mm; 256  256  256]. Diffusion-weighted
images were acquired using single-shot echo planar imaging (EPI) with a
twice-refocused spin echo sequence to reduce eddy-current-induced dis-
tortions (TR, 6090ms; TE, 91.7ms; field of view, 23 cm; 128 128). Each
three-dimensional (3D) volume consisted of 55 axial slices (2.0 mm/0
mm gap; 1.79 1.79 mm in-plane resolution). We acquired 105 images
per subject: 11 with no diffusion sensitization (i.e., T2-weighted b0 im-
ages) and 94 diffusion-weighted (DW) images (b  1149 s/mm2) with
gradient directions evenly distributed on the hemisphere.
DTI preprocessing.We automatically removed nonbrain regions from the
T1-weighted MR and DW b0 images using FSL BET (http://fsl.fmrib.
ox.ac.uk/fsl/), then manually refined the brain extraction. All T1-
weighted images were linearly aligned to a common space (with a global
transform that had 9 degrees of freedom). The raw DW images were
corrected for eddy current distortions using the FSL “eddy correct”
method (http://fsl.fmrib.ox.ac.uk/fsl/). Individual b0 images were aver-
aged, linearly aligned, and resampled to their corresponding T1 images.
The average b0 maps were then elastically registered to the individual
common space T1-weighted scans using amutual information cost func-
tion (Leow et al., 2005) to control for EPI-induced susceptibility artifacts.
Computing fractional anisotropy.We compared FA values at each voxel
acrossCLU genotypes. Diffusion tensorswere computed at each voxel using
FSL software (http://fsl.fmrib.ox.ac.uk/fsl/). From the tensor eigenvalues
(1, 2, 3), FA was calculated according to the following formula:
FA  32 1   2  2   2  3   212  22  32
 0,1	
 
1  2  3
3
.
We also analyzed radial diffusivity (Drad) (the average of 2 and 3) and
axial diffusivity (Dax) (1) to clarify the extent to which each might be
contributing to the changes in FA.
Template creation and registration. We used nonlinear fluid registra-
tion (Lepore et al., 2008) to create a mean deformation target (MDT)
from the FA images (calculated after b0 susceptibility correction) (Jah-
anshad et al., 2010). Included in the MDT were 32 randomly selected
unrelated subjects (16 female/16 male). The N 3D vector fields that flu-
idly registered a specific individual to all other N subjects were averaged
and applied to that subject, preserving the image intensities and anatom-
ical features of the template subject.
Susceptibility-corrected FA maps were registered to the final
population-averaged FA-based MDT using a 3D elastic warping tech-
nique with a mutual information cost function (Leow et al., 2005). To
better align white matter regions of interest, the MDT and all whole-
brain registered FA maps were thresholded at 0.25 (excluding contribu-
tions from non-white matter). Thresholded FA maps were then re-
registered to the thresholdedMDT and smoothedwith a Gaussian kernel
(9 mm full width at half-maximum). In this way, the outlines of the
major white matter structures are stable and have been normalized to a
very fine degree of matching across subjects, greatly reducing the
neuroanatomical variations in these structures across subjects. To
ensure that our results were not due to morphometric differences that
were not fully corrected by the fluid registration, we additionally
performed tissue-specific, smoothing-compensated voxel-based
analysis (T-SPOON) (Lee et al., 2009), which reduces that confound.
Statistical analyses. We performed mixed-model regression at each
voxel tomodel family relatedness (Kang et al., 2008). A symmetricNN
kinshipmatrix was constructed to describe the relationship of every sub-
ject to all others. A kinship matrix coefficient of 1 denoted the relation-
ship of the subjects to themselves or their MZ twin: 0.5 indicated DZ
twins and siblings within the same family, and 0 denoted unrelated sub-
jects. Ancestry outliers were removed, so no additional modeling was
used in the kinship matrix to adjust for population genetic structure
between families. We then used a linear mixed-effects model to estimate
the association of each copy ofCLU-C in the SNP rs11136000 to FA, Dax,
Braskie et al. • CLU Gene Influences White Matter Integrity J. Neurosci., May 4, 2011 • 31(18):6764–6770 • 6765
and Drad measures at each voxel, controlling for familial relatedness
through the kinship matrix, age, and sex.
Our analysis used an additivemodel that assessed the effect of each risk
allele rather than evaluating the effects of CLU-C carriers or noncarriers
(i.e., we counted the number of adverse alleles and used that number in a
regression across the full sample). The CLU association with AD initially
was discovered using a test for differences in allele frequencies between
diagnostic groups. Here we use a quantitative phenotype, so that test
cannot be used. However, the additive model we used (vs a recessive or
dominant model) is the most powerful for finding genetic effects in a
quantitative phenotype. To further investigate the nature of this relation-
ship, we used post hoc exploratory tests to evaluate how CLU genotype
related to FA using models other than the additive model to compare
genotype groups, while controlling for age and sex. Specifically, we eval-
uated C/C versus T, T/T versus C, C/T versus T/T, and C/T versus C/C
carrier. This must be considered exploratory
testing because we chose the additive model as
our primary hypothesis since it is the most pow-
erful model to use if the effects are additive.
To ensure that only white matter was being
considered and to reduce the effects of partial
voluming, only voxels in which FA  0.3 in
the MDT were considered in the statistical
analyses. The p value reported is based on the
fixed-effect regression coefficient ( param-
eter) of the additive genetic effect (see Fig. 1).
This analysis was performed using Efficient
Mixed-Model Association (Kang et al., 2008)
(EMMA; http://mouse.cs.ucla.edu/emma/)
within the R statistical package (version
2.9.2; http://www.r-project.org/). We used
the widely used false discovery rate (FDR)
method to control for voxelwise multiple
comparisons (Benjamini and Hochberg, 1995).
Single-factor ANOVAs were used to evaluate
whether genotype groups were different in age,
sex, or IQ. We also controlled for age and sex in
the full sample, and age, sex, and full IQ in a sub-
sample of 378 subjects for whom IQ values were
available.
Results
As shown in Table 1, genotype groups
(T/T, C/T, andC/C)were not significantly
different in age (F(2, 395) 1.30, p 0.27),
verbal IQ (F(2, 375) 0.31, p 0.73), per-
formance IQ (F(2, 375) 0.82, p 0.44), or
full-scale IQ (F(2, 375) 0.65, p 0.53), as
tested using ANOVAs. Sex was not sig-
nificantly different between genotype
groups, as determined using a  2 test
( 2(2)  0.84, p  0.66).
White matter integrity was quantified
using the widely accepted index FA. In
statistical maps based on 398 young
adults, each CLU-C allele (adjusted for
age and sex) was associated with lower FA
in frontal, temporal, parietal, occipital,
and subcortical white matter (multiple
comparisons corrected: critical p 0.023,
for an FDR controlled at 5%; minimum
p 5.9 10
7; 46.1%of evaluated voxels
survived the FDR threshold). Brain re-
gions with lower FA included corticocor-
tical pathways previously demonstrated
to have lower FA in AD patients and
Figure 1. FA association with CLU-C displayed on a study-specific FA template. a, Highlighted areas are the p values indicating
voxels in which CLU-C is associated with lower FA after adjusting for age and sex (FDR critical p value 0.023). In b, we show
regression coefficients at significant voxels that encompass many regions that degenerate in AD. The left brain hemisphere is
displayed on the right. Coordinates listed are for the Z (for axial slices) and X (for the sagittal slice) directions in ICBM space. SLF and
ILF denote the superior and inferior longitudinal fasciculi. IFO is the inferior fronto-occipital fasciculus.
Table 1. Subject characteristics by CLU rs11136000 genotype in the studied
population
Genotypes
T/T C/T C/C
Subjects 68 220 110
Sex 24 M, 44 F 77 M, 143 F 44 M, 66 F
Age 23.6 2.3 23.5 2.2 23.9 2.3
No. of IQ test scores 64 208 106
PIQ 112.4 17.0 115.2 15.8 114.0 14.4
VIQ 111.3 10.8 112.2 11.3 112.7 10.0
FIQ 112.8 12.9 114.8 13.1 114.5 11.1
Values are given as themean SD. Sex, age, and IQ scores are not significantly different between genotype groups
( p 0.05) using ANOVAs to evaluate group differences in age and IQ, and a2 test to evaluate differences in sex.
M, Male; F, female; PIQ, performance IQ; VIQ, verbal IQ; FIQ, full-scale IQ.
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APOE4 carriers. Strongest effects (0.01 units FA reduction per
risk allele) were found in the splenium, bilateral posterior and
anterior corona radiata, bilateral perithalamic tracts, and poste-
rior thalamic radiation, and complex association fibers [left SLF,
and ILF/inferior fronto-occipital fasciculus (IFO)]. We also
found significant associations bilaterally in peristriatal and
periventricular white matter, other callosal fibers (corpus callo-
sum body and genu, and forceps major andminor), limbic tracts
(fornix, stria terminalis, and posterior cingulum, including in the
parahippocampal white matter), complex association fibers
(SLF, ILF/IFO), and tracts of the cerebral peduncles (Fig. 1). Our
results remained significant when adjusted for age, sex, and full-
scale IQ in the 378 subjects for whom IQ values were available
(multiple comparisons corrected: critical p 0.028, for an FDR
controlled at 5%; minimum p 1.9 10
7; 56.3% of evaluated
voxels survived the FDR threshold).
FA was significantly correlated with CLU genotype after FDR
correction using the additive model. The additive model outper-
formed all the other models for comparing genotype categories,
and therefore best explains the underlying effect in our sample.
Using an uncorrected p 0.05 threshold for illustrative purposes
only, we report the following when all subjects were considered:
those with a T/T genotype showed regionally greater FA than C
carriers in 36% of voxels considered at this liberal statistical
threshold (minimum p 8.9 10
6). Those with a C/C geno-
type showed lower FA thanT carriers in 40%of voxels considered
at this liberal statistical threshold (minimum p  7.0  10
5)
(Fig. 2). When 220 subjects with a C/T genotype were compared
with either 110 subjects with a C/C genotype or 68 with a T/T
genotype, 14% (minimum p 3.6 10
4) and 10% (minimum
p 3.6 10
5) of considered voxels, respectively, were signifi-
cant at an uncorrected p 0.05 level. Overall, this evidence favors
an additive (allele dose-dependent) effect on the white matter.
FA is influenced by both Dax (ameasure of diffusion along the
axonal fibers) and Drad (a measure of diffusion perpendicular to
the axonal fibers). Reduced white matter integrity (as measured
by FA) can sometimes be further traced back to greater Drad or
lower Dax. To further investigate the reduced FA in CLU-C car-
riers, we examined the correlation ofCLU genotypewithDrad and
Dax on a voxelwise basis, while adjusting for age and sex. Each
CLU-C allele was associated with increased Drad (multiple com-
parisons corrected: critical p  0.022, for an FDR controlled at
5%; minimum p  0.0001; 44.3% of evaluated voxels survived
the FDR threshold) after adjusting for age and sex (Fig. 3). Dax
was not significantly associated with CLU genotype.
DTI studies have reported lower FA in healthy olderAPOE4
subjects in the parahippocampal white matter, splenium, and
fronto-occipital fasciculus (Nierenberg et al., 2005; Persson et al.,
2006; Smith et al., 2010). To determine whether our results were
influenced by APOE genotypes, we evaluated the effects on DTI
FA of a proxy or tag SNP for the APOE4 polymorphism
rs2075650 within the TOMM40 gene, because the APOE4 poly-
morphismwas not directly genotyped on the chip. TheTOMM40
variant is in moderate linkage disequilibrium with APOE4 (r2
0.48) (Harold et al., 2009). Our CLU results remained significant
after adjusting for age, sex, and TOMM40 genotype (corrected
for multiple comparisons; critical p  0.026, for an FDR con-
trolled at 5%; minimum p  6.1  10
7; 51.1% of evaluated
voxels survived the FDR threshold). These results confirm that
the CLU-C effect on FA was not attributable to TOMM40 geno-
types, and hence APOE4-associated changes.
Finally, to reduce the likelihood that coregistration errors
contributed to our results, we performed an analysis known as
T-SPOON (Lee et al., 2009) on our data using individual FA
masks thresholded at FA0.25. We then reran the primary sta-
tistical analysis, adjusting for age and sex, and using the same
thresholding and spatial smoothing as in the primary analyses.
The T-SPOON analysis adjusts for effects at the interfaces of
white matter and other tissues. Our results remained significant
(corrected for multiple comparisons; critical p  0.019, for an
FDR controlled at 5%; minimum p  1.2  10
5; 37.8% of
evaluated voxels survived the FDR threshold) in all the same
brain regions as our primary analysis. This is in line with expecta-
tion, as most of the differences were found far away from any gray
matter and reflect differences in the characteristics ofwhitematter in
many regions without partial volume of multiple tissue types.
Discussion
We found widespread lower FA in the white matter of healthy
young adults who carry a recently identified risk gene for late-
onset Alzheimer’s disease. Effects occurred in multiple regions,
including several known to degenerate in AD. Such regions in-
cluded the corpus callosum, fornix, cingulum, SLF, and ILF (Liu
et al., 2009; Stricker et al., 2009). This suggests that the CLU-C
related variability found here might create a local vulnerability
important for disease onset. These effects are remarkable as they
already exist early in life and are associated with a risk gene that is
very prevalent (36% of Caucasians carry two copies of the risk-
conferring genetic variant CLU-C).
Higher FA does not always imply better neuronal function,
and there are neurogenetic syndromes where higher FA in some
Figure 2. Statistical models. Highlighting represents un-normalized regression coefficients
or beta values in all white matter voxels tested. It demonstrates the CLU-C association with
lower FA (after adjusting for age and sex). a, b, Shown here as post hoc explorations are the C/C
versus T carrier model (a) and the T/T versus C carrier model (b). Units are in FA unit difference
between groups for these models, while they are in FA units per allele for the additive model
(Fig. 1). The per-voxel effect is similar in location using all models, but only the initially hypoth-
esized and most powerful additive model passes FDR correction, as shown in Figure 1 (FDR
critical p value  0.023). The effect appears to depend on the allele dose rather than the
presence or absence of a given allele. The left brain hemisphere is displayed on the right.
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brain regions is associated with abnormal
function (Hoeft et al., 2007). Accepting
these as counterexamples, lower FA is
generally a sign of poorer fiber coherence,
myelination, and poorer function, as
noted in a recent review of DTI studies
across many domains of neuropsychiatry
(Thomason and Thompson, 2011).
Lower FA may indicate reduced my-
elin integrity or axonal damage.We found
a significant increase in Drad widely
throughout the white matter without as-
sociated significant decreases in Dax.
These results suggest that reduced myelin
integrity, rather than axonal degenera-
tion, may be responsible for the lower FA
we found in many of these regions (Di
Paola et al., 2010). Increased regional Drad
has previously been demonstrated in AD
patients versus controls (Choi et al., 2005;
Stricker et al., 2009; Zhang et al., 2009; Di
Paola et al., 2010; Salat et al., 2010) and in
healthy APOE4 subjects versus those
who do not carry the APOE4 allele
(Nierenberg et al., 2005). In AD patients,
increased Drad has been attributed to de-
generation of the myelin sheath (Di Paola
et al., 2010), but our demonstration of in-
creased Drad in healthy young CLU-C carriers raises the question
of whether the increased Drad seen in AD patients in past studies
may also stem in part from inadequate myelination that occurs
developmentally as a result of genes that increase AD risk. This is
not to say that reduced myelin integrity does not play a role in
AD, but rather that both developmental differences and age- or
disease-related degeneration may contribute to that reduced
integrity.
Genetic risk for reduced FA may increase the risk for later
cognitive impairment through developmental insufficiency. A
lesser degree of myelination in CLU-C carriers may arise during
development, which may not translate into poorer cognition in
youth as the brain can compensate via redundant functionality.
However, when exacerbated by other factors, such as age-related
neuronal atrophy, and plaque and tangle burden in AD, reduced
myelin integrity could facilitate cognitive impairment. As our
study examined howa commonADrisk gene affects young adults
who have no observable cognitive deficits, it is unlikely that we
are seeing the earliest possible signs of AD-associated brain
changes. More likely, the reduced fiber integrity represents an
early developmental vulnerability that may reduce brain resil-
ience to later AD pathology; in other words, its mechanism of
action may not be part of the classic AD pathways that lead to
abnormal amyloid plaque and neurofibrillary tangle accumula-
tion in the brain.
Lower FA in late-onset Alzheimer’s disease may be promoted
by suboptimal amyloid processing in the brain. Amyloid plaques
and neurofibrillary tangles—the primary pathological hallmarks
of AD—accumulate in the brain decades before symptoms ap-
pear. Neurofibrillary tangles are detectable in 20% of subjects
aged 26–35 years (Braak and Braak, 1997), and greater amyloid
deposition in healthy elderly subjects is correlated with greater
neuropsychological decline over the preceding decade (Resnick
et al., 2010). Clusterin is found in amyloid plaques (Calero et al.,
1999) and transports soluble -amyloid (A) across the blood–
brain barrier into brain parenchyma (Zlokovic et al., 1996). A
then may damage the oligodendrocytes, which generate myelin,
as reported in vitro (Roth et al., 2005). However, in our young
healthy sample, lower FA may reflect variability in lipid process-
ing as the lipid-rich myelin sheath develops; it is unlikely to be
evidence of a disease mechanism or a biomarker of AD. Myelin
abnormalities and axonal swelling may contribute to synaptic
loss and precede amyloid deposition in AD (Bartzokis, 2009). If
so, the CLU risk variant could increase AD risk in two ways: an
early acquired vulnerability pairedwith suboptimal amyloid pro-
cessing in later life.
Although the additive model we used assesses evidence for an
aggregate risk of carrying increasing numbers of alleles, the asso-
ciated cellular processes that result in lower FA are not necessarily
the primary pathways by which the SNP confers AD risk. Rather,
our findings suggest oneway inwhich vulnerability to ADmay be
increased.
Thus far, only one neuroimaging study has examined brain
differences inCLU-C carriers (Biffi et al., 2010). That study found
that the CLU genotypes were not associated with MRI measures.
However, in that study structural MRI was used, which is less
sensitive than DTI to altered fiber microstructure and myelina-
tion. The authors of that study noted that the effects on brain
structure of different gene variants that increase AD risk may be
specific to particular and disparate aspects of brain structure.
This segregation of gene effect on neuroimaging traits can offer
important insights into themechanisms through which the poly-
morphisms impact AD risk (Biffi et al., 2010).
While 398 subjects would be a small sample on which to iden-
tify new genetic risk factors for AD using genome-wide associa-
tion scanning, it is in fact the largest DTI study to date to examine
the effects of Alzheimer’s disease genetic risk factors on DTI FA.
Prior studies found effects of APOE4 on FA in sample sizes that
ranged from29 to 69 (Nierenberg et al., 2005; Persson et al., 2006;
Honea et al., 2009; Smith et al., 2010). The effects of familial AD
Figure 3. Radial diffusivity. Drad but not Dax showed a significant CLU genotype effect after adjusting for age and sex. In
highlighted voxels, Drad is significantly greaterwith each CLU allele C (multiple comparisons corrected: criticalp0.022 for an FDR
of 5%). The left brain hemisphere is shown on the right.
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genes were detected in only 20 adults (Ringman et al., 2007).
Admittedly, the odds ratios for those risk factors are greater than
for CLU. However, our statistical power was boosted not only by
our much larger sample size of 398 subjects, but also by our
scanning at a stronger field strength (4 T, as opposed to 1.5 or 3 T
in the previous studies) and withmore diffusion-weighted gradi-
ents (94 in our study vs 6 or 12 in previous studies). It is therefore
not surprising that we had the power to detect the existing effect.
Although the CLU risk variant was a candidate gene, whose
effects we set out here to assess, onemay also consider the value of
making a correction, across studies, for examining multiple AD
risk genes. Because of the very strict voxelwise corrections for
multiple comparisons required in imaging genetics when using
FDR, the rates of false positives (even when examining several
hundred SNPs that are not expected to have a significant relation-
ship with the data) remains well below 0.05 (0.2–4.1% for 720
SNPs), as determined empirically (Meyer-Lindenberg et al.,
2008). The fact that the CLU rs11136000 is a candidate variant
chosen a priori based on its relationship to lipid transport and
Alzheimer’s disease makes it unlikely that our strong results were
due to false positives.
We do not yet have available to us a comparably large dataset
in which to independently replicate our results. This remains a
limitation of our study as genetic studies typically employ very
large samples, and, where possible, they replicate effects to avoid
the risk of false discoveries. Continued data collection and col-
laborative efforts that allow for larger sample sizes will remedy
this in the future. However, our results remain valuable as a focus
for ongoing efforts by our group and others.
Quantitative mapping of structural brain differences in those
at genetic risk for AD is crucial for evaluating treatment and
prevention strategies. Once identified, brain differences can be
monitored to determine how lifestyle choices influence brain
health and disease risk. Many lifestyle factors that heighten the
risk for dementia—such as exercise and body mass index—have
effects on brain structure and the level of brain atrophy (Ho et al.,
2010b,c; Raji et al., 2010). Additionally, regular exercise and a
healthful diet may reduce the risk of cognitive decline, particu-
larly in those genetically at risk for AD (Rovio et al., 2005; Scar-
meas et al., 2009) or those carrying common risk alleles generally
associated with brain structure deficits in healthy adults (Ho et
al., 2010a). Targeting adults at greatest risk for cognitive deterio-
ration can also improve the power of clinical trials (Kohannim et
al., 2010). Future DTI studies of CLU-C in those imaged with
amyloid- or tangle-sensitive positron emission tomography
probes will also help to relate lower white matter integrity to AD
pathology as it emerges.
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